Sentinel lymph node biopsy for lung cancer

被引:0
作者
Alexander Gregor
Hideki Ujiie
Kazuhiro Yasufuku
机构
[1] University of Toronto,Division of Thoracic Surgery, Toronto General Hospital, University Health Network
[2] Hokkaido University Graduate School of Medicine,Department of Cardiovascular and Thoracic Surgery
来源
General Thoracic and Cardiovascular Surgery | 2020年 / 68卷
关键词
Sentinel lymph node (SLN); Non-small cell lung cancer (NSCLC); Indocyanine green (ICG); Near-infrared (NIR);
D O I
暂无
中图分类号
学科分类号
摘要
Sentinel lymph node biopsy is a technique to identify the first lymph node (or nodes) draining a tumor. The underlying principle is that as the first site of cancer spread, evaluation of the sentinel node will be most predictive for wider nodal involvement. The introduction of sentinel node biopsy revolutionized the surgical management of cutaneous melanoma and breast cancer, becoming a key component in the management of such patients. For over 20 years, thoracic surgeons have similarly worked to apply this technique to lung cancer but have thus far not had the same impact on lung surgery. In this review, we will summarize the ongoing discussions on the role of sentinel node biopsy in lung cancer, the methods for identifying the sentinel node, and the techniques for evaluating the sentinel node specimen. We will also highlight some of the pressing questions investigators should consider when designing a trial for sentinel node mapping. This will clarify the current status of sentinel node biopsy in lung cancer and thus highlight important future directions for research.
引用
收藏
页码:1061 / 1078
页数:17
相关论文
共 412 条
  • [1] Gao SJ(2017)Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT Lung Cancer 109 36-41
  • [2] Kim AW(1992)Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 392-399
  • [3] Puchalski JT(2006)Omission of mediastinal lymph node dissection in lung cancer: its techniques and diagnostic procedures Ann Thorac Cardiovasc Surg 12 83-88
  • [4] Bramley K(2006)Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial Ann Thorac Surg 81 1013-1020
  • [5] Detterbeck FC(2011)Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial J Thorac Cardiovasc Surg 141 662-668
  • [6] Boffa DJ(2012)Segmentectomy for selected cT1N0M0 non-small cell lung cancer: a prospective study at a single institute J Thorac Cardiovasc Surg 144 87-93
  • [7] Morton DL(2010)Required area of lymph node sampling during segmentectomy for clinical stage IA non-small cell lung cancer J Thorac Cardiovasc Surg 139 38-42
  • [8] Wen DR(2012)Thoracoscopic segmentectomy with intraoperative evaluation of sentinel nodes for stage I non-small cell lung cancer Ann Thorac Cardiovasc Surg 18 89-94
  • [9] Wong JH(2018)Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer J Thorac Cardiovasc Surg 155 1280-1291
  • [10] Economou JS(1999)Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique J Thorac Cardiovasc Surg 117 220-224